Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.
The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients.
FTY720 for cancer therapy (Review).
Electrolyte imbalance triggering relapse of inflammatory neuropathy.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Osmotic demyelination syndrome in Intensive Care Unit.
Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease.
Methionyl-tRNA Formyltransferase (MTFMT) Deficiency Mimicking Acquired Demyelinating Disease.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Exercise barriers and preferences among women and men with multiple sclerosis.
Targeting two-pore domain potassium channels - A promising strategy for treating T cell mediated autoimmunity.
Obesity and HLA in multiple sclerosis: Weighty matters.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.
Reading, writing, and reserve: Literacy activities are linked to hippocampal volume and memory in multiple sclerosis.
Glial cell biology in the Great Lakes region.
Culturing microglia from the neonatal and adult central nervous system.
Factors associated with unemployment among persons with multiple sclerosis.
Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.
Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
Pages
« first
‹ previous
…
443
444
445
446
447
448
449
450
451
…
next ›
last »